‘Big 5’ will be expired in patents this year… it is like the night before a storm in the pharmaceutical industry

In 2015, it is expected to be inevitable for the pharmaceutical industry to compete for the so-called ‘Big 5’treatments.

Among the Big 5, the Lilly’s ‘Alimta’ will be the first one to be expired in this May, and the Pfizer’s ‘Celebrex’ and the Dong-A ST’s ‘Stillen’ will follow its track in June and July. Moreover, the Lilly’s ‘Cialis’ and the BMS’s ‘Baraclude’ will be expired in September and ...